Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 4/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 4/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 4/20 | 0.46 |
| ▸ | PRSS3 | P35030 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 15/20 | 0.44 |
| ▸ | CA1 | P00915 | 14/20 | 0.43 |
| ▸ | MMP1 | P03956 | 6/20 | 0.43 |
| ▸ | MMP2 | P08253 | 6/20 | 0.43 |
| ▸ | MMP9 | P14780 | 6/20 | 0.43 |
| ▸ | MMP8 | P22894 | 6/20 | 0.43 |
| ▸ | MMP13 | P45452 | 6/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27991564 | 0.98 | CA2 (0.48) | F2PRSS1PRSS2PRSS3CA2 | |
| SCHEMBL8406248 | 0.92 | F2 (0.38) | F2PRSS1PRSS2PRSS3CA2 | |
| SCHEMBL781139 | 0.87 | USP2 (0.35) | F2PRSS1PRSS2PRSS3CA2 | |
| SCHEMBL1697233 | 0.83 | F2 (0.32) | F2PRSS1PRSS2PRSS3 | |
| SCHEMBL4297517 | 0.81 | USP2 (0.35) | F2PRSS1PRSS2PRSS3CA2 | |
| SCHEMBL167861 | 0.79 | CA2 (0.48) | F2PRSS1PRSS2PRSS3CA2 | |
| SCHEMBL1146256 | 0.77 | CA2 (0.52) | F2PRSS1PRSS2PRSS3CA2 | |
| SCHEMBL11802495 | 0.77 | CA2 (0.52) | F2PRSS1PRSS2PRSS3CA2 | |
| SCHEMBL8437170 | 0.77 | CA2 (0.52) | F2PRSS1PRSS2PRSS3CA2 | |
| SCHEMBL6396150 | 0.77 | CA2 (0.52) | F2PRSS1PRSS2PRSS3CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114315531-A | Photosensitizer with high photosensitive activity and preparation method thereof | 宁波南大光电材料有限公司 | 2022-04-12 | — | — | CN | claimed |
| JP-58216166-A | — | — | None | — | — | JP | disclosed |
| CN-118363270-A | Negative photosensitive resin composition, method for producing cured relief pattern, and semiconductor device | 旭化成株式会社 | 2024-07-19 | — | — | CN | disclosed |
| EP-4263646-A1 | STABILIZED EPOXY-ISOCYANATE MIXTURES AND OXAZOLIDINONE CONTAINING POLYMERS OBTAINED THEREFROM | BASF SE (DE) | 2023-10-25 | — | — | EP | disclosed |
| US-20230173078-A1 | SMARCA DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2023-06-08 | — | — | US | disclosed |
| CN-110088680-B | Double-layer photosensitive layer roll | 旭化成株式会社 | 2022-12-30 | — | — | CN | disclosed |
| WO-2022136048-A1 | STABILIZED EPOXY-ISOCYANATE MIXTURES AND OXAZOLIDINONE CONTAINING POLYMERS OBTAINED THEREFROM | BASF SE (DE) | 2022-06-30 | — | — | WO | disclosed |
| CN-114315531-A | Photosensitizer with high photosensitive activity and preparation method thereof | 宁波南大光电材料有限公司 | 2022-04-12 | — | — | CN | disclosed |
| CN-112585536-A | Photosensitive resin composition, dry film, cured product, and electronic component | 太阳控股株式会社 | 2021-03-30 | — | — | CN | disclosed |
| CN-107329367-B | Photosensitive resin composition, method for producing cured relief pattern, semiconductor device, and display device | 旭化成株式会社 | 2021-03-23 | — | — | CN | disclosed |
| US-6528232-B1 | Chemically amplified photoresist composition using the novel sulfonium salt compound as the photoacid generator | NEC CORPORATION (JP) | 2003-03-04 | — | — | US | disclosed |
| US-20020182535-A1 | Photoacid generator containing two kinds of sulfonium salt compound, chemically amplified resist containing the same and pattern transfer method | NEC CORPORATION (JP) | 2002-12-05 | — | — | US | disclosed |
| EP-0898556-B1 | A PROCESS FOR THE PRODUCTION OF HYDROFLUOROETHERS | MINNESOTA MINING & MFG (US) | 2001-12-12 | — | — | EP | disclosed |
| EP-0898556-A1 | A PROCESS FOR THE PRODUCTION OF HYDROFLUOROETHERS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-03-03 | — | — | EP | disclosed |
| US-5750797-A | CONTACTING A FLUORINATED CARBONYL-CONTAINING COMPOUND WITH AN ALKYLATING AGENT IN THE PRESENCE OF AN ANHYDROUS SOURCE OF FLUORIDE ION AND A TERTIARY AMINE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-05-12 | — | — | US | disclosed |
| WO-1997038962-A1 | A PROCESS FOR THE PRODUCTION OF HYDROFLUOROETHERS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-10-23 | — | — | WO | disclosed |
| US-5470523-A | Process of molding products by rim | BAYER AKTIENGESELLSCHAFT (DE) | 1995-11-28 | — | — | US | disclosed |
| US-5173559-A | Polyisocyanate, stabilized epoxide, isocyanate-reactive group, polyisocyanurates; pot life | BAYER AKTIENGESELLSCHAFT (DE) | 1992-12-22 | — | — | US | disclosed |
| US-5021536-A | Curable mixtures of polyisocyanates, epoxides, alyklating agent to inhibit polymerization | BAYER AKTIENGESELLSCHAFT (DE) | 1991-06-04 | — | — | US | disclosed |
| JP-S58216166-A | PRODUCTION OF N-SUBSTITUTED IMIDAZOLE | KYOWA HAKKO KOGYO CO LTD | 1983-12-15 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230173078-A1 | SMARCA DEGRADERS AND USES THEREOF | SMARCA1, SMARCA2, SMARCC2 | F2 4344/4885PRSS1 1439/4885PRSS2 1898/4885 |
| US-20020182535-A1 | Photoacid generator containing two kinds of sulfonium salt compound, chemically amplified resist containing the same and pattern transfer method | ASIC1, ASIC3, SULT1A1 | F2 3437/4885PRSS1 854/4885PRSS2 543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.